Understanding Immunity through the Lens of Disease Ecology

Trends in Immunology

Volumn 38, Issue 12, 2017, Pages 888-903

  Hedrick, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE; VIRULENCE FACTOR;

ECOLOGY; HOST PARASITE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNOLOGY; INFECTION; INFECTIOUS AGENT; NONHUMAN; PARASITE TRANSMISSION; PARASITE VIRULENCE; PARASITISM; POPULATION DENSITY; POPULATION SIZE; POPULATION STRUCTURE; PREDICTION; REVIEW; THEORY; TRADE OFF THEORY; ANIMAL; BIOLOGICAL MODEL; DISEASE TRANSMISSION; EVOLUTION; HOST PATHOGEN INTERACTION; MIXED INFECTION; VIRULENCE; ZOONOSIS;

ANIMALS; BIOLOGICAL EVOLUTION; COINFECTION; DISEASE TRANSMISSION, INFECTIOUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; INFECTION; MODELS, IMMUNOLOGICAL; VIRULENCE; VIRULENCE FACTORS; ZOONOSES;

EID: 85028633281     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2017.08.001     Document Type: Review

References (133)

1. Taylor, L.H., et al. Risk factors for human disease emergence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 (2001), 983–989.
2. Woolhouse, M.E., et al. Emerging pathogens: the epidemiology and evolution of species jumps. Trends Ecol. Evol. 20 (2005), 238–244.
3. Mandl, J.N., et al. Reservoir host immune responses to emerging zoonotic viruses. Cell 160 (2015), 20–35.
4. Zapata, J.C., Salvato, M.S., Arenavirus variations due to host-specific adaptation. Viruses 5 (2013), 241–278.
5. Ermonval, M., et al. What do we know about how Hantaviruses interact with their different hosts. Viruses, 8, 2016, E223.
6. Holmes, E.C., et al. The evolution of Ebola virus: insights from the 2013–2016 epidemic. Nature 538 (2016), 193–200.
7. Screaton, G., et al. New insights into the immunopathology and control of dengue virus infection. Nat. Rev. Immunol. 15 (2015), 745–759.
8. Wild, T.F., Henipaviruses: a new family of emerging Paramyxoviruses. Pathol. Biol. (Paris) 57 (2009), 188–196.
9. Cressler, C.E., et al. The adaptive evolution of virulence: a review of theoretical predictions and empirical tests. Parasitology 143 (2016), 915–930.
10. Silverstein, A.M., A History of Immunology. 2nd edn, 2009, Elsevier.
11. Strogatz, S.H., Exploring complex networks. Nature 410 (2001), 268–276.
12. Wilson, E.O., Consilience: The Unity of Knowledge. 1998, Vintage Books p. 85.
13. Hoffmann, J.A., et al. Innate immunity in higher insects. Curr. Opin. Immunol. 8 (1996), 8–13.
14. Brennan, C.A., Anderson, K.V., Drosophila: the genetics of innate immune recognition and response. Annu. Rev. Immunol. 22 (2004), 457–483.
15. Ayres, J.S., et al. Identification of Drosophila mutants altering defense of and endurance to Listeria monocytogenes infection. Genetics 178 (2008), 1807–1815.
16. Choi, O., Rutschmann, S., Dissecting immunity by germline mutagenesis. Immunology 137 (2012), 124–130.
17. Casanova, J.L., Severe infectious diseases of childhood as monogenic inborn errors of immunity. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E7128–E7137.
18. Casanova, J.L., Abel, L., Primary immunodeficiencies: a field in its infancy. Science 317 (2007), 617–619.
19. Casadevall, A., Pirofski, L., Host-pathogen interactions: the attributes of virulence. J. Infect. Dis. 184 (2001), 337–344.
20. Sadd, B.M., Schmid-Hempel, P., Principles of ecological immunology. Evol. Appl. 2 (2009), 113–121.
21. Archie, E.A., et al. Infecting epidemiology with genetics: a new frontier in disease ecology. Trends Ecol. Evol. 24 (2009), 21–30.
22. Cremer, S., et al. Social immunity. Curr. Biol. 17 (2007), R693–R702.
23. de Roode, J.C., Lefèvre, T., Behavioral immunity in insects. Insects 3 (2012), 789–820.
24. Beale, E., et al. Caenorhabditis elegans senses bacterial autoinducers. Appl. Environ. Microbiol. 72 (2006), 5135–5137.
25. Pradel, E., et al. Detection and avoidance of a natural product from the pathogenic bacterium Serratia marcescens by Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 2295–2300.
26. Meisel, J.D., et al. Chemosensation of bacterial secondary metabolites modulates neuroendocrine signaling and behavior of C. elegans. Cell 159 (2014), 267–280.
27. Rivière, S., et al. Formyl peptide receptor-like proteins are a novel family of vomeronasal chemosensors. Nature 459 (2009), 574–577.
28. Oaten, M., et al. Disgust as a disease-avoidance mechanism. Psychol. Bull. 135 (2009), 303–321.
29. Curtis, V., et al. Disgust as an adaptive system for disease avoidance behaviour. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366 (2011), 389–401.
30. Schneider, D.S., Ayres, J.S., Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases. Nat. Rev. Immunol. 8 (2008), 889–895.
31. Råberg, L., et al. Decomposing health: tolerance and resistance to parasites in animals. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364 (2009), 37–49.
32. Little, T.J., et al. The coevolution of virulence: tolerance in perspective. PLoS Pathog., 6, 2010, e1001006.
33. Sears, B.F., et al. The economy of inflammation: when is less more?. Trends Parasitol. 27 (2011), 382–387.
34. Medzhitov, R., et al. Disease tolerance as a defense strategy. Science 335 (2012), 936–941.
35. Schafer, J.F., Tolerance to plant disease. Annu. Rev. Phytopathol. 9 (1971), 235–252.
36. Baucom, R.S., de Roode, J.C., Ecological immunology and tolerance in plants and animals: tolerance in plants and animals. Funct. Ecol. 25 (2011), 18–28.
37. Anderson, R.M., May, R.M., Infectious Diseases of Humans: Dynamics and Control. 1992, Oxford University Press.
38. Kermack, W.O., McKendrick, A.G., Contributions to the mathematical theory of epidemics – I. 1927. Bull. Math. Biol. 53 (1991), 33–55.
39. Anderson, R.M., May, R.M., Coevolution of hosts and parasites. Parasitology 85 (1982), 411–426.
40. Greenwood, M., et al. Experimental epidemiology. Medical Research Council Special Report Series. JAMA 107 (1936), 1971–1972.
41. Anderson, R.M., May, R.M., Population biology of infectious diseases: part I. Nature 280 (1979), 361–367.
42. Fenner, F., Ratcliffe, F.N., Myxomatosis. 1965, Cambridge University Press.
43. Fenner, F., Changes in the mortality-rate due to myxomatosis in the Australian wild rabbit. Nature 172 (1953), 228–230.
44. Fenner, F., Deliberate introduction of the European rabbit, Oryctolagus cuniculus, into Australia. Rev. Sci. Tech. 29 (2010), 103–111.
45. Marshall, I.D., Fenner, F., Studies in the epidemiology of infectious myxomatosis of rabbits. VII. The virulence of strains of myxoma virus recovered from Australian wild rabbits between 1951 and 1959. J. Hyg. (Lond) 58 (1960), 485–488.
46. Kerr, P.J., Myxomatosis in Australia and Europe: a model for emerging infectious diseases. Antiviral Res. 93 (2012), 387–415.
47. Kerr, P.J., et al. Myxoma virus and the Leporipoxviruses: an evolutionary paradigm. Viruses 7 (2015), 1020–1061.
48. Van Valen, L., A new evolutionary law. Evol. Theory 1 (1973), 1–30.
49. Ebert, D., Hamilton, W.D., Sex against virulence: the coevolution of parasitic diseases. Trends Ecol. Evol. 11 (1996), 79–82.
50. Hedrick, S.M., The acquired immune system: a vantage from beneath. Immunity 21 (2004), 607–615.
51. Decaestecker, E., et al. Host-parasite ‘Red Queen’ dynamics archived in pond sediment. Nature 450 (2007), 870–873.
52. Lively, C.M., An epidemiological model of host-parasite coevolution and sex. J. Evol. Biol. 23 (2010), 1490–1497.
53. Kerr, P.J., et al. Evolutionary history and attenuation of myxoma virus on two continents. PLoS Pathog., 8, 2012, e1002950.
54. André, J.B., et al. Within-host parasite dynamics, emerging trade-off, and evolution of virulence with immune system. Evolution 57 (2003), 1489–1497.
55. Legrand, J., et al. Understanding the dynamics of Ebola epidemics. Epidemiol. Infect. 135 (2007), 610–621.
56. Diehl, W.E., et al. Ebola virus glycoprotein with increased infectivity dominated the 2013–2016 epidemic. Cell 167 (2016), 1088–1098 e6.
57. Urbanowicz, R.A., et al. Human adaptation of Ebola virus during the West African outbreak. Cell 167 (2016), 1079–1087 e5.
58. Bull, J.J., Lauring, A.S., Theory and empiricism in virulence evolution. PLoS Pathog., 10, 2014, e1004387.
59. Alizon, S., et al. Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future. J. Evol. Biol. 22 (2009), 245–259.
60. Bull, J.J., Ebert, D., Invasion thresholds and the evolution of nonequilibrium virulence. Evol. Appl. 1 (2008), 172–182.
61. Lively, C.M., The ecology of virulence. Ecol. Lett. 9 (2006), 1089–1095.
62. Ebert, D., Experimental evolution of parasites. Science 282 (1998), 1432–1435.
63. Sabin, A.B., Boulger, L.R., History of Sabin attenuated poliovirus oral live vaccine strains. J. Biol. Stand. 1 (1973), 115–118.
64. Johnson, P.T., et al. Biodiversity decreases disease through predictable changes in host community competence. Nature 494 (2013), 230–233.
65. Bartlett, M.S., The critical community size for measles in the United States. J. R. Stat. Soc. A 123 (1960), 37–44.
66. Black, F.L., Measles endemicity in insular populations: critical community size and its evolutionary implication. J. Theor. Biol. 11 (1966), 207–211.
67. Black, F.L., Infectious diseases in primitive societies. Science 187 (1975), 515–518.
68. Haraguchi, Y., Sasaki, A., The evolution of parasite virulence and transmission rate in a spatially structured population. J. Theor. Biol. 203 (2000), 85–96.
69. Erdös, P., Rényi, A., On the evolution of random graphs. Bull. Inst. Int. Stat. 38 (1960), 343–347.
70. Karoński, M., A review of random graphs. J. Graph Theory 6 (1982), 349–389.
71. Callaway, D.S., et al. Network robustness and fragility: percolation on random graphs. Phys. Rev. Lett. 85 (2000), 5468–5471.
72. Albert, R., Barabási, A.-L., Statistical mechanics of complex networks. Rev. Mod. Phys. 74 (2002), 47–97.
73. Miller, J.C., Percolation and epidemics in random clustered networks. Phys. Rev. E Stat. Nonlinear Soft Matter Phys., 80, 2009, 020901.
74. Milgram, S., The small-world problem. Psychol. Today 1 (1967), 61–67.
75. Travers, J., Milgram, S., An experimental study of the small world problem. Sociometry 32 (1969), 425–443.
76. Watts, D.J., Strogatz, S.H., Collective dynamics of 'small-world’ networks. Nature 393 (1998), 440–442.
77. Zuev, K., et al. Hamiltonian dynamics of preferential attachment. J. Phys. A Math. Theor., 49, 2016, 105001.
78. Pastor-Satorras, R., Vespignani, A., Epidemic spreading in scale-free networks. Phys. Rev. Lett. 86 (2001), 3200–3203.
79. May, R.M., Lloyd, A.L., Infection dynamics on scale-free networks. Phys. Rev. E Stat. Nonlin. Soft Matter Phys., 64, 2001, 066112.
80. Boguñá, M., et al. Absence of epidemic threshold in scale-free networks with degree correlations. Phys. Rev. Lett., 90, 2003, 028701.
81. Barthélemy, M., et al. Velocity and hierarchical spread of epidemic outbreaks in scale-free networks. Phys. Rev. Lett., 92, 2004, 178701.
82. Ewald, P.W., Host-parasite relations, vectors, and the evolution of disease severity. Annu. Rev. Ecol. Syst. 14 (1983), 465–485.
83. Ewald, P.W., The evolution of virulence: a unifying link between parasitology and ecology. J. Parasitol. 81 (1995), 659–669.
84. Day, T., Parasite transmission modes and the evolution of virulence. Evolution 55 (2001), 2389–2400.
85. Veugelers, P.J., et al. Determinants of HIV disease progression among homosexual men registered in the Tricontinental Seroconverter Study. Am. J. Epidemiol. 140 (1994), 747–758.
86. Fenn, E., Biological warfare in eighteenth-century North America: beyond Jeffery Amherst. J. Am. Hist. 86 (2000), 1552–1580.
87. Walther, B.A., Ewald, P.W., Pathogen survival in the external environment and the evolution of virulence. Biol. Rev. Camb. Philos. Soc. 79 (2004), 849–869.
88. Bailey, D., Cholera. 2011, Rosen Publishing.
89. McNeill, W.H., Plagues and Peoples. 1976, Anchor Press/Doubleday.
90. Galvani, A.P., Epidemiology meets evolutionary ecology. Trends Ecol. Evol. 18 (2003), 132–139.
91. Armelagos, G.J., et al. Evolutionary, historical and political economic perspectives on health and disease. Soc. Sci. Med. 61 (2005), 755–765.
92. Virgin, H.W., et al. Redefining chronic viral infection. Cell 138 (2009), 30–50.
93. Woolhouse, M., Gaunt, E., Ecological origins of novel human pathogens. Crit. Rev. Microbiol. 33 (2007), 231–242.
94. Bocquet-Appel, J.-P., et al. Estimates of Upper Palaeolithic meta-population size in Europe from archaeological data. J. Archaeol. Sci. 32 (2005), 1656–1668.
95. Li, H., et al. Inference of human population history from individual whole-genome sequences. Nature 475 (2011), 493–496.
96. Zahid, H.J., et al. Agriculture, population growth, and statistical analysis of the radiocarbon record. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 931–935.
97. Goldewijk, K.K., et al. Long-term dynamic modeling of global population and built-up area in a spatially explicit way: HYDE 3. 1. Holocene 20 (2010), 565–573.
98. Tallavaara, M., et al. Human population dynamics in Europe over the Last Glacial Maximum. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 8232–8237.
99. Diamond, J.M., Guns, Germs, and Steel: The Fates of Human Societies. 1997, W.W. Norton, 199–214.
100. Wolfe, N.D., et al. Origins of major human infectious diseases. Nature 447 (2007), 279–283.
101. Crosby, A.W., Virgin soil epidemics as a factor in the aboriginal depopulation in America. William Mary Q., 33, 1976, 289.
102. Fenner, F., Smallpox: emergence, global spread, and eradication. Hist. Philos. Life Sci. 15 (1993), 397–420.
103. Black, F.L., Why did they die?. Science 258 (1992), 1739–1740.
104. Mann, C.C., 1491: New Revelations of the Americas before Columbus. 2005, Albert A. Knopf.
105. Hedrick, P.W., Population genetics of malaria resistance in humans. Heredity (Edinb) 107 (2011), 283–304.
106. Baron, J.M., et al. A revised timeline for the origin of Plasmodium falciparum as a human pathogen. J. Mol. Evol. 73 (2011), 297–304.
107. Carter, R., Mendis, K.N., Evolutionary and historical aspects of the burden of malaria. Clin. Microbiol. Rev. 15 (2002), 564–594.
108. Hedrick, P.W., Resistance to malaria in humans: the impact of strong, recent selection. Malar. J., 11, 2012, 349.
109. Zhernakova, A., et al. Evolutionary and functional analysis of celiac risk loci reveals SH2B3 as a protective factor against bacterial infection. Am. J. Hum. Genet. 86 (2010), 970–977.
110. Zhernakova, A., et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet., 7, 2011, e1002004.
111. Yang, H., et al. IFIH1 gene polymorphisms in type 1 diabetes: genetic association analysis and genotype-phenotype correlation in Chinese Han population. Autoimmunity 45 (2012), 226–232.
112. Vasseur, E., et al. The evolutionary landscape of cytosolic microbial sensors in humans. Am. J. Hum. Genet. 91 (2012), 27–37.
113. Sironi, M., Pathogen-driven selection in the human genome. Int. J. Evol. Biol., 2013, 2013, 204240.
114. Laayouni, H., et al. Convergent evolution in European and Rroma populations reveals pressure exerted by plague on Toll-like receptors. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), 2668–2673.
115. Ramos, P.S., et al. Genes associated with SLE are targets of recent positive selection. Autoimmune Dis., 2014, 2014, 203435.
116. Quach, H., et al. Genetic adaptation and neandertal admixture shaped the immune system of human populations. Cell 167 (2016), 643–656 e17.
117. Mina, M.J., et al. Vaccines. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 348 (2015), 694–699.
118. Perelson, A.S., et al. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271 (1996), 1582–1586.
119. Grenfell, B.T., et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 303 (2004), 327–332.
120. Murphy, F.A., Emerging zoonoses. Emerg. Infect. Dis. 4 (1998), 429–435.
121. Han, B.A., et al. Global patterns of zoonotic disease in mammals. Trends Parasitol. 32 (2016), 565–577.
122. Peters, D.P., et al. Cross-scale interactions, nonlinearities, and forecasting catastrophic events. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 15130–15135.
123. Gupta, S., et al. Chaos, persistence, and evolution of strain structure in antigenically diverse infectious agents. Science 280 (1998), 912–915.
124. Gupta, S., Anderson, R.M., Population structure of pathogens: the role of immune selection. Parasitol. Today 15 (1999), 497–501.
125. Handel, A., et al. Towards a quantitative understanding of the within-host dynamics of influenza A infections. J. R. Soc. Interface 7 (2010), 35–47.
126. Banerjee, S., et al. Estimating biologically relevant parameters under uncertainty for experimental within-host murine West Nile virus infection. J. R. Soc. Interface, 13, 2016, 20160130.
127. Rongvaux, A., et al. Development and function of human innate immune cells in a humanized mouse model. Nat. Biotechnol. 32 (2014), 364–372.
128. + cells efficiently engraft human cytokine knock-in mice. Blood, 2016, 10.1182/blood-2015-10-676452 Published online August 19, 2016.
129. Beura, L.K., et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature 532 (2016), 512–516.
130. Reese, T.A., et al. Sequential infection with common pathogens promotes human-like immune gene expression and altered vaccine response. Cell Host Microbe 19 (2016), 713–719.
131. Farber, D.L., et al. Immunological memory: lessons from the past and a look to the future. Nat. Rev. Immunol. 16 (2016), 124–128.
132. Urrutia, A., et al. Standardized whole-blood transcriptional profiling enables the deconvolution of complex induced immune responses. Cell Rep. 16 (2016), 2777–2791.
133. Brodin, P., Davis, M.M., Human immune system variation. Nat. Rev. Immunol. 17 (2017), 21–29.